This has a direct impact on the utility of this marker as the presence and early recognition of beta hCG can be used to prognosticate the disease by clubbing it along with the other commonly used tumour markers of ER, PR, Her2neu and Ki67 thereby increasing the screening of such patients and aiding in the earlier detection of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.